DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Average Recommendation of “Hold” from Analysts

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) have received an average recommendation of “Hold” from the thirteen brokerages that are currently covering the stock, MarketBeat reports. Eleven analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $20.36.

Several research firms have commented on XRAY. Needham & Company LLC reaffirmed a “hold” rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. Jefferies Financial Group downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating and decreased their price target for the stock from $30.00 to $20.00 in a report on Thursday, January 23rd. Wells Fargo & Company cut their target price on DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating for the company in a research note on Friday, February 28th. Barrington Research lifted their price target on shares of DENTSPLY SIRONA from $20.00 to $21.00 and gave the company an “outperform” rating in a research report on Monday. Finally, Mizuho dropped their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating for the company in a research note on Thursday, March 13th.

Insider Transactions at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier acquired 15,142 shares of the business’s stock in a transaction dated Monday, March 3rd. The shares were acquired at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the acquisition, the director now directly owns 81,971 shares in the company, valued at approximately $1,353,341.21. The trade was a 22.66% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 0.50% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in XRAY. Treasurer of the State of North Carolina lifted its position in DENTSPLY SIRONA by 0.6% during the fourth quarter. Treasurer of the State of North Carolina now owns 88,854 shares of the medical instruments supplier’s stock valued at $1,686,000 after buying an additional 560 shares in the last quarter. UMB Bank n.a. grew its position in DENTSPLY SIRONA by 60.8% in the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock valued at $28,000 after acquiring an additional 564 shares in the last quarter. Blue Trust Inc. lifted its holdings in DENTSPLY SIRONA by 10.9% in the 4th quarter. Blue Trust Inc. now owns 7,199 shares of the medical instruments supplier’s stock worth $137,000 after buying an additional 707 shares in the last quarter. Quarry LP lifted its position in shares of DENTSPLY SIRONA by 25.7% during the fourth quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier’s stock worth $72,000 after purchasing an additional 780 shares during the last quarter. Finally, Federated Hermes Inc. grew its stake in DENTSPLY SIRONA by 0.5% in the fourth quarter. Federated Hermes Inc. now owns 169,304 shares of the medical instruments supplier’s stock worth $3,213,000 after purchasing an additional 915 shares in the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Stock Performance

Shares of XRAY stock opened at $16.45 on Thursday. The company has a market cap of $3.28 billion, a P/E ratio of -7.95, a PEG ratio of 1.80 and a beta of 0.92. The firm has a fifty day moving average price of $14.38 and a 200 day moving average price of $17.48. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA has a 12 month low of $12.16 and a 12 month high of $28.50.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.14. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The firm had revenue of $879.00 million during the quarter, compared to the consensus estimate of $854.75 million. During the same period in the prior year, the company posted $0.42 earnings per share. The firm’s quarterly revenue was down 7.8% compared to the same quarter last year. Sell-side analysts predict that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were issued a $0.16 dividend. The ex-dividend date of this dividend was Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 3.89%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -14.10%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.